Hubei Mengyang Pharmaceutical Co., Ltd.'s exclusive medical insurance product - Shengbai Oral Liquid (mixture) - has been selected by more than 100 experts nationwide for its precise clinical efficacy and sufficient evidence-based evidence. It has been successfully included in the 2022 edition of the "Clinical Pathway Therapy Drug Definition - Tumor Disease Volume" and "Clinical Pathway Therapy Drug Definition - Hematology Volume".

(Interpretation of Clinical Pathway Therapeutic Drugs)

The clinical pathway is a standardized and standardized diagnostic and treatment standard developed by hospital management personnel, physicians, caregivers, pharmacists, medical technicians, and other multidisciplinary experts, integrating various diagnostic and treatment measures such as examination, testing, diagnosis, treatment, and nursing for specific diseases or combinations of cases. Carrying out clinical pathway work is an important way to achieve healthcare optimization, systematization, standardization, and full process quality management.